A recent study (Bergqvist et al, 2007) used quantitative real-time PCR (Q-PCR) and RNA expression profiles (RNA-EP) to evaluate HER2 status in relation to clinical outcome in breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.